Question 1

What is Castleman disease?

Accepted Answer

Castleman disease is a benign lymphoproliferative disorder that affects the lymphatic system and can present in either a localized or multicentric form. In the localized type, individuals may have a discrete group of enlarged lymph nodes, while the multicentric form is characterized by widespread lymphadenopathy along with systemic symptoms. The exact prevalence is not well established, and the condition is considered uncommon. Its cause is not linked to any known genetic mutations and appears to result from complex immune and inflammatory processes.

Question 2

What are the symptoms of Castleman disease?

Accepted Answer

Individuals with Castleman disease often present with enlarged lymph nodes, which can be found in the mediastinum, abdomen, or other regions. Many experience systemic features such as weight loss, fatigue, and anemia, as well as laboratory indications of inflammation like an elevated erythrocyte sedimentation rate and increased circulating C-reactive protein. Other symptoms, including abdominal pain, nausea, vomiting, and jaundice, may develop and vary in severity between patients. Not all individuals experience all features, and severity varies considerably.

Question 3

What causes Castleman disease?

Accepted Answer

The precise genetic basis of Castleman disease is under investigation, and no specific genes have been implicated in its development. As such, there is no defined inheritance pattern associated with this condition. Castleman disease is thought to result from complex interactions within the immune system that lead to abnormal lymph node proliferation and an inflammatory response. Given the current understanding, family history does not appear to play a significant role in the risk for developing this condition.

Question 4

How rare is Castleman disease?

Accepted Answer

Castleman disease is classified as not well established. The estimated prevalence is approximately Unknown. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 5

How is Castleman disease diagnosed?

Accepted Answer

Due to the overlap of its symptoms with other conditions, the diagnosis of Castleman disease relies on a combination of clinical evaluation, imaging studies, and histopathologic examination of lymph node tissue. Although molecular genetic testing is the gold standard for inherited disorders, in the case of Castleman disease the diagnosis is primarily established through tissue biopsy and supportive laboratory assessments showing markers of inflammation. Because many features can be seen in other disorders, definitive diagnosis requires integrating clinical, laboratory, and histological findings.

Question 6

Are there treatments for Castleman disease?

Accepted Answer

Currently, management focuses on supportive care and symptom management since there are no treatments specifically approved for Castleman disease. Treatment is tailored to the individual and typically involves a multidisciplinary team to address both systemic symptoms and local manifestations. Regular surveillance is an essential part of long-term care, helping to identify potential complications before they become serious. Patients should discuss treatment options with their healthcare team to determine which supportive strategies may be most appropriate for their specific situation.

Question 7

Are there clinical trials for Castleman disease?

Accepted Answer

Yes, there are currently 21 active clinical trials for Castleman disease registered on ClinicalTrials.gov. Clinical trials test new treatments, procedures, or approaches. Your healthcare provider can help determine if a trial might be appropriate for your situation. Visit the Treatment section of this page for more details.

Question 8

What complications can arise from Castleman disease?

Accepted Answer

Complications from Castleman disease can vary widely among individuals. Some may experience significant systemic involvement, leading to severe symptoms like weight loss, fatigue, and anemia. Regular monitoring is important to catch any potential complications early, as timely intervention can help manage these issues effectively.

Question 9

How does Castleman disease affect daily life and activities?

Accepted Answer

Living with Castleman disease can be challenging, as symptoms like fatigue and pain may impact daily activities. Patients often need to adjust their routines and may require support from family and friends. It's important to communicate with healthcare providers about managing symptoms to maintain a good quality of life.

Question 10

What is the prognosis for someone diagnosed with Castleman disease?

Accepted Answer

The prognosis for Castleman disease can vary greatly from person to person. Some individuals may have mild symptoms and a stable course, while others might experience more severe issues. Early diagnosis and access to a multidisciplinary care team can improve outcomes and help manage the disease effectively.

Question 11

Should families consider genetic counseling for Castleman disease?

Accepted Answer

Since Castleman disease is not linked to known genetic mutations and does not have a defined inheritance pattern, genetic counseling may not be necessary for most families. However, discussing family history and individual concerns with a healthcare provider can provide clarity and support for those affected by the disease.

Organ System	Phenotype Count	Example Features
Digestive system	7	Abdominal pain, Jaundice, Nausea and vomiting

Research Type	Count	% of Total
Patient case studies	75	41%
Research summaries	61	33%
Disease patterns and progression	15	8%
Laboratory research	11	6%
Clinical study results	8	4%
Other research	7	4%
Testing and diagnosis research	7	4%
New treatment approaches	1	1%

Kisho

Castleman disease

Overview

Clinical Presentation

Diagnosis

Treatment

Approved Therapies

Prognosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

Clinical Trials

Recent Publications

Latest News & Developments

Contrast-Enhanced Ultrasound in the Diagnosis of Parotid Gland Castleman Disease in a Child.

Castleman Disease: Unraveling Diagnostic Challenges Through Clinical and Pathologic Perspectives.

Clinical Characteristics and Surgical Outcomes of Retroperitoneal Unicentric Castleman Disease: A Single-Center Retrospective Study.

Castleman disease

Overview

Clinical Presentation

Diagnosis

Treatment

Approved Therapies

Prognosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is Castleman disease?

What are the symptoms of Castleman disease?

What causes Castleman disease?

How rare is Castleman disease?

How is Castleman disease diagnosed?

Are there treatments for Castleman disease?

Are there clinical trials for Castleman disease?

What complications can arise from Castleman disease?

How does Castleman disease affect daily life and activities?

What is the prognosis for someone diagnosed with Castleman disease?

Should families consider genetic counseling for Castleman disease?

Explore clinical features

Clinical Trials

Recent Publications

Latest News & Developments

Contrast-Enhanced Ultrasound in the Diagnosis of Parotid Gland Castleman Disease in a Child.

Castleman Disease: Unraveling Diagnostic Challenges Through Clinical and Pathologic Perspectives.

Clinical Characteristics and Surgical Outcomes of Retroperitoneal Unicentric Castleman Disease: A Single-Center Retrospective Study.